Core Insights - The announcement on October 10, 2025, states that Xiang Chen has been appointed as the fund manager for the Great Wall SSE Sci-Tech Innovation Board 100 Index Enhanced Fund (023446) effective from the same date [1] - As of October 9, 2025, the net value of the fund was 1.3956, reflecting an increase of 0.88% from the previous day [1] Fund Manager Background - Xiang Chen, a Chinese national with a master's degree, joined Great Wall Fund Management Co., Ltd. in August 2019, serving as a quantitative researcher and investment manager assistant [1] - He has been the fund manager for the Great Wall Core Preferred Flexible Allocation Mixed Securities Investment Fund since October 28, 2022, and for the Great Wall CSI Pharmaceutical Health Index Enhanced Securities Investment Fund since September 15, 2023 [1] Fund Performance - The following are the funds managed by Xiang Chen along with their respective sizes and performance: - Great Wall Core Preferred Mixed A (Code: 000030) with a size of 0.67 billion, has a return of 5.55% since October 28, 2022 [1] - Great Wall CSI Pharmaceutical Health Index Enhanced A (Code: 014205) with a size of 0.11 billion, has a return of -14.78% from September 15, 2023, to July 17, 2024 [1] - Great Wall CSI Pharmaceutical P Index Enhanced C (Code: 014206) with a size of 0.11 billion, has a return of -14.99% from September 15, 2023, to July 17, 2024 [1] - Great Wall Core Preferred Mixed C (Code: 019274) with a size of 0.00 billion, has a return of 18.36% since September 13, 2023 [1] Stock Performance Review - In the third quarter of 2023, the Great Wall Core Preferred Mixed A fund added Shaanxi Coal and Chemical Industries, with an average entry price of 22.73. After holding for one year and one quarter, it exited in the fourth quarter of 2024 at an average exit price of 31.49, resulting in an estimated return of 38.54% [1]